Snapshot 3: Connectathon 32 Base

This is Snapshot #3 for FHIR R5, released to support Connectathon 32. For a full list of available versions, see the Directory of published versions.

Example MedicationRequest/medrx0306 (XML)

Pharmacy Work GroupMaturity Level: N/AStandards Status: InformativeCompartments: Encounter, Patient, Practitioner

Raw XML (canonical form + also see XML Format Specification)

Jump past Narrative

Oral Chemotherapy Order - Myleran - completed - with reasonCode (id = "medrx0306")

<?xml version="1.0" encoding="UTF-8"?>

<MedicationRequest xmlns="http://hl7.org/fhir">
    <id value="medrx0306"/> 
    <text> <status value="generated"/> <div xmlns="http://www.w3.org/1999/xhtml"><p> <b> Generated Narrative: MedicationRequest</b> <a name="medrx0306"> </a> </p> <div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border:
       1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource MedicationRequest &quot;medrx0306&quot; </p> </div> <p> <b> identifier</b> : id: 12345689 (use: OFFICIAL)</p> <p> <b> status</b> : active</p> <p> <b> intent</b> : order</p> <h3> Medications</h3> <table class="grid"><tr> <td> -</td> <td> <b> Reference</b> </td> </tr> <tr> <td> *</td> <td> <a name="med0304"> </a> <blockquote> <p/>  <p> <a name="med0304"> </a> </p> <p> <b> code</b> : Myleran 2mg tablet, film coated <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/4.0.0/CodeSystem-v3-ndc.html">National drug codes</a> #76388-713-25)</span> </p> </blockquote> </td> </tr> </table> <p> <b> subject</b> : <a href="patient-example-a.html">Patient/pat1: Donald Duck</a>  &quot;Donald DUCK&quot;</p> <p> <b> authoredOn</b> : 2015-01-15</p> <p> <b> requester</b> : <a href="practitioner-example-f007-sh.html">Practitioner/f007: Patrick Pump</a>  &quot;Simone HEPS&quot;</p> <h3> Reasons</h3> <table class="grid"><tr> <td> -</td> <td> <b> Concept</b> </td> </tr> <tr> <td> *</td> <td> Chronic myeloid Leukemia (disorder) <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://browser.ihtsdotools.org/">SNOMED CT</a> #92818009)</span> </td> </tr> </table> <blockquote> <p> <b> dose</b> </p> <blockquote> <p> <b> dosageInstruction</b> </p> <p> <b> sequence</b> : 1</p> <p> <b> text</b> : 6 mg PO daily for remission induction; adjust dosage to white blood cell (WBC)
             count.  With hold treatment if WBC is less than 15,000/µL; resume when WBC is greater
             than 50,000/µL</p> <p> <b> timing</b> : Once per 1 days</p> <p> <b> route</b> : Oral route (qualifier value) <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://browser.ihtsdotools.org/">SNOMED CT</a> #26643006)</span> </p> </blockquote> </blockquote> </div> </text> <contained> 
        <Medication> 
            <id value="med0304"/> 
            <code> 
                <coding> 
                    <system value="http://hl7.org/fhir/sid/ndc"/> 
                    <code value="76388-713-25"/> 
                    <display value="Myleran 2mg tablet, film coated"/> 
                </coding> 
            </code> 
        </Medication> 
    </contained> 
    <identifier> 
        <use value="official"/> 
        <system value="http://www.bmc.nl/portal/prescriptions"/> 
        <value value="12345689"/> 
    </identifier> 
    <status value="active"/> 
    <intent value="order"/> 
    <medication> 
        <reference> 
        <reference value="#med0304"/> 
        <display value="Myleran 2mg tablet"/> 
        </reference> 
    </medication> 
    <subject> 
            <!--    Linked to the resource patient who needs the medication    -->
        <reference value="Patient/pat1"/> 
        <display value="Donald Duck"/>    
    </subject> 
    <authoredOn value="2015-01-15"/> 
    <requester> 
            <!--    Linked to the practitioner who treats patient    -->
        <reference value="Practitioner/f007"/> 
        <display value="Patrick Pump"/> 
        </requester> 
    <reason> 
      <concept> 
        <coding> 
            <system value="http://snomed.info/sct"/> 
            <code value="92818009"/> 
            <display value="Chronic myeloid Leukemia (disorder)"/> 
        </coding> 
      </concept> 
    </reason> 
    <dose> 
    <dosageInstruction> 
        <sequence value="1"/> 
        <text value="6 mg PO daily for remission induction; adjust dosage to white blood cell (WBC)
       count.  With hold treatment if WBC is less than 15,000/µL; resume when WBC is greater
       than 50,000/µL"/> 
        <timing> 
            <repeat> 
                <frequency value="1"/> 
                <period value="1"/> 
                <periodUnit value="d"/> 
            </repeat> 
        </timing> 
        <route> 
            <coding> 
                <system value="http://snomed.info/sct"/> 
                <code value="26643006"/> 
                <display value="Oral route (qualifier value)"/> 
            </coding> 
        </route> 
        <doseAndRate> 
            <type> 
                <coding> 
                    <system value="http://terminology.hl7.org/CodeSystem/dose-rate-type"/> 
                    <code value="ordered"/> 
                    <display value="Ordered"/> 
                </coding> 
            </type> 
            <doseQuantity> 
                <value value="6"/> 
                <unit value="mg"/> 
                <system value="http://unitsofmeasure.org"/> 
                <code value="mg"/> 
            </doseQuantity> 
        </doseAndRate> 

    </dosageInstruction> 
    </dose> 
</MedicationRequest> 

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.